Evidence map›Paper›PMID 33804173›Full record

ArticleViruses2021

Human Protoparvovirus DNA and IgG in Children and Adults with and without Respiratory or Gastrointestinal Infections.

Ushanandini Mohanraj, Maija Jokinen, Rajita Rayamajhi Thapa, Minna Paloniemi, Timo Vesikari, Maija Lappalainen, Eveliina Tarkka, Zaiga Nora-Krūkle, Anda Vilmane, Kim Vettenranta and 6 more

Open access · goldAbstract read
In one paragraph

Article in Viruses, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.0field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 5 institutions in 3 countries.

Ushanandini MohanrajDepartment of Virology, University of Helsinki, 00290 Helsinki, Finland.ORCID 0000-0002-5336-0603
Maija JokinenDepartment of Virology, University of Helsinki, 00290 Helsinki, Finland.ORCID 0000-0002-5007-7933
Rajita Rayamajhi ThapaDepartment of Virology, University of Helsinki, 00290 Helsinki, Finland.
Minna PaloniemiFaculty of Medicine and Health Technology, Tampere University, 33100 Tampere, Finland.
Timo VesikariNordic Research Network Oy, 33700 Tampere, Finland.
Maija LappalainenHelsinki University Hospital Laboratory (HUSLAB), 00290 Helsinki, Finland.ORCID 0000-0002-0560-8600
Eveliina TarkkaHelsinki University Hospital Laboratory (HUSLAB), 00290 Helsinki, Finland.
Zaiga Nora-KrūkleInstitute of Microbiology and Virology, Rīga Stradiņš University, 1067 Riga, Latvia.ORCID 0000-0002-0594-1091
Anda VilmaneInstitute of Microbiology and Virology, Rīga Stradiņš University, 1067 Riga, Latvia.ORCID 0000-0002-1738-013X
Kim VettenrantaHelsinki University Hospital, 00280 Helsinki, Finland.
Charles ManganiCollege of Medicine, University of Malawi, Blantyre 3, Malawi.
Sami OikarinenFaculty of Medicine and Health Technology, Tampere University, 33100 Tampere, Finland.
Yue-Mei FanFaculty of Medicine and Health Technology, Tampere University, 33100 Tampere, Finland.
Per AshornFaculty of Medicine and Health Technology, Tampere University, 33100 Tampere, Finland.ORCID 0000-0003-2311-2593
Elina VäisänenDepartment of Virology, University of Helsinki, 00290 Helsinki, Finland.
Maria Söderlund-VenermoDepartment of Virology, University of Helsinki, 00290 Helsinki, Finland.ORCID 0000-0002-4582-8317
University of Helsinki · FITampere University · FIHelsinki University Hospital · FIRiga Stradiņš University · LVUniversity of Malawi · MW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Three human protoparvoviruses, bufavirus (BuV), tusavirus (TuV) and cutavirus (CuV), have recently been discovered in diarrheal stool. BuV has been associated with diarrhea and CuV with cutaneous T-cell lymphoma, but there are hardly any data for TuV or CuV in stool or respiratory samples. Hence, using qPCR and IgG enzyme immunoassays, we analyzed 1072 stool, 316 respiratory and 445 serum or plasma samples from 1098 patients with and without gastroenteritis (GE) or respiratory-tract infections (RTI) from Finland, Latvia and Malawi. The overall CuV-DNA prevalences in stool samples ranged between 0-6.1% among our six patient cohorts. In Finland, CuV DNA was significantly more prevalent in GE patients above rather than below 60 years of age (5.1% vs 0.2%). CuV DNA was more prevalent in stools among Latvian and Malawian children compared with Finnish children. In 10/11 CuV DNA-positive adults and 4/6 CuV DNA-positive children with GE, no known causal pathogens were detected. Interestingly, for the first time, CuV DNA was observed in two nasopharyngeal aspirates from children with RTI and the rare TuV in diarrheal stools of two adults. Our results provide new insights on the occurrence of human protoparvoviruses in GE and RTI in different countries.

Indexed as

AdolescentAdultAgedAged, 80 and overChildChild, PreschoolCohort StudiesDNA, ViralFecesFemaleFinlandGastrointestinal DiseasesHumansInfantLatviaMalawiDNA, ViralbufaviruscutavirusgastroenteritisleukemiaparvovirusPCRrespiratory-tract infectionserologytusavirus

Identifiers

PMID33804173
PMCPMC7999311
OpenAlexW3138679185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.